The invention is directed to novel aminomethyl-pyrroloquinazoline compounds and pharmaceutical compositions thereof which are useful thrombin receptor or PAR-1 antagonists, methods for production thereof and methods for treating thrombin or PAR-1 mediated disorders.
本发明涉及新型
氨甲基
吡咯喹唑啉化合物及其药物组合物,它们是有用的凝血酶受体或 PAR-1 拮抗剂、其生产方法以及治疗凝血酶或 PAR-1 介导的疾病的方法。